# FDA Inspection 1200074 - Azurity Pharmaceuticals, Inc. - March 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/64bfb086-1201-4189-ba58-78d85ea96314
Source feed: FDA_Inspections

> FDA Inspection 1200074 for Azurity Pharmaceuticals, Inc. on March 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200074
- Company Name: Azurity Pharmaceuticals, Inc.
- Inspection Date: 2023-03-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255484 - 2024-11-14](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/0a94deb7-070c-4c8a-a83d-064cf9d967d6)

Company: https://www.keypedia.com/companies/azurity-pharmaceuticals-inc/bc97bdba-f1c1-4152-99eb-962174d79b31

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c